Sanofi To Navigate Tariff Impact With $20 Billion In Spending Through 2030

Benzinga15:58 ET

Shares of Pharmaceutical Stocks Are Trading Lower. The Sector May Down on Continued Weakness Amid President Trump's Drug Pricing Executive Order.

Benzinga15:27 ET

Beyond The Numbers: 16 Analysts Discuss Regeneron Pharmaceuticals Stock

Benzinga15:00 ET

Unpacking the Latest Options Trading Trends in Eli Lilly

Benzinga12:02 ET

This PVH Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday

BenzingaMay 14 08:58 ET

Regeneron Pharmaceuticals Analyst Ratings

BenzingaMay 14 08:20 ET · Ratings

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

BenzingaMay 13 12:15 ET

This Caterpillar Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

BenzingaMay 13 08:47 ET

Argenx Analyst Ratings

BenzingaMay 13 08:23 ET · Ratings

"Don't sell if prices don't drop!" Trump enforces a mandatory minimum drug price for developed countries, but a lawsuit battle may be "reenacted".

① An executive order signed on the 12th of October, USA time, requires that the payment price of pharmaceuticals in the USA be forcibly anchored to the lowest level of other developed countries within 30 days; ② There is strong opposition within the USA, and industry experts estimate that a legal battle is about to "replay"; ③ As the market-oriented USA begins to wield the big stick of administrative pricing, the underlying rules of the game for Innovative Drugs have quietly been rewritten.

cls.cnMay 12 20:52 ET

The "Most-Favored-Nation Pricing" policy for Trump Medicine has been issued: benchmarked against developed countries, complete the Quote within 30 days.

① This policy aims to align prescription drug pricing in the USA with that of "Other developed countries". Trump has requested that the Quote be completed within 30 days; ② The scope of affected Pharmaceuticals is still unclear, and the White House has stated that the government will pay special attention to drugs that have the "largest price differences and highest spending"; ③ Trump had implemented a similar policy before the end of his last term, but it was blocked by the courts and ultimately fell through.

cls.cnMay 12 12:33 ET

Roche Plans $700M North Carolina Facility

Seeking AlphaMay 12 10:53 ET

Innovation, Pharma Profits Won't Suffer Under Trump Prescription Drug EO - White House

Seeking AlphaMay 12 10:00 ET

Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday

BenzingaMay 12 09:46 ET

Trump's Drug Price Cuts: Will They Work?

Moomoo News GlobalMay 12 09:35 ET

Wynn Resorts, Microsoft, Palantir And A Health Care Stock On CNBC's 'Final Trades'

BenzingaMay 12 09:20 ET

This Wayfair Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

BenzingaMay 12 09:08 ET

'Trump To Sign Order To Cut Some U.S. Drug Prices To Match Those Abroad' - CNBC

BenzingaMay 12 09:00 ET

Today's Pre-Market Movers and Top Ratings | TSLA, NVDA, LLY and More

Movers and ShakersMay 12 08:29 ET

Teva Pharmaceutical Indus Analyst Ratings

BenzingaMay 12 08:18 ET · Ratings